ライフサイエンスコーパス: pregnancy complication

1 therapeutic options to prevent this serious pregnancy complication.

2 assessing a woman's risk of developing this pregnancy complication.

3 ampsia (PE) is a dangerous and unpredictable pregnancy complication.

4 ces may be related to preeclampsia, a common pregnancy complication.

5 ant expression of host genes associated with pregnancy complications.

6 l tobacco smoke exposure are associated with pregnancy complications.

7 trol (DES) given to their mothers to prevent pregnancy complications.

8 -10 proficiency protects against CpG-induced pregnancy complications.

9 l infections are a well-established cause of pregnancy complications.

10 a good treatment for women with aPL-induced pregnancy complications.

11 oach to antiphospholipid syndrome-associated pregnancy complications.

12 ciation with abnormal placental function and pregnancy complications.

13 identify a new effector of immune-triggered pregnancy complications.

14 e to the placental dysfunction seen in human pregnancy complications.

15 ht contribute to the pathogenesis of certain pregnancy complications.

16 neural tube defects, Alzheimer disease, and pregnancy complications.

17 block C5a-C5a receptor interactions prevent pregnancy complications.

18 sociation between maternal periodontitis and pregnancy complications.

19 ower reproductive success and higher risk of pregnancy complications.

20 isorder and GAD do not contribute to adverse pregnancy complications.

21 eloping personalised medicine approaches for pregnancy complications.

22 ities to prevent and treat infection-related pregnancy complications.

23 trophoblasts, reduces the risk of developing pregnancy complications.

24 ising target for therapeutic manipulation of pregnancy complications.

25 but may paradoxically lead to virus-related pregnancy complications.

26 rsal approach for mitigating immune-mediated pregnancy complications.

27 term birth was examined after stratifying by pregnancy complications.

28 tcomes included the live-birth rate and late pregnancy complications.

29 l testing for aneuploidies and prediction of pregnancy complications.

30 he prevention of recurrent placenta-mediated pregnancy complications.

31 activation may be a culprit in postsurgical pregnancy complications.

32 oembolism or with previous placenta-mediated pregnancy complications.

33 in ICP cases were associated with coexisting pregnancy complications.

34 and/or prevention of inflammation-associated pregnancy complications.

35 pregnant women with prior placenta-mediated pregnancy complications.

36 to the development of preeclampsia and other pregnancy complications.

37 tinct from HCA and not entirely explained by pregnancy complications.

38 6 (95% CI, 1.15-3.02) after stillbirth vs no pregnancy complications.

39 e third, and are associated with the risk of pregnancy complications.

40 heparin in the prevention of recurrent late pregnancy complications.

41 ry outcome was a composite end point of late-pregnancy complications.

42 with reduced UBF, even after controlling for pregnancy complications.

43 arin effectively prevents recurrence of late pregnancy complications, 135 women with previous history

44 First described as a pregnancy complication 80 years ago, hemolytic disease o

45 We used two mouse models of pregnancy complications: a mouse model of obstetrics ant

46 onin reuptake inhibitor (SSRI) treatment and pregnancy complications, accounting for psychiatric diag

47 With the exception of pregnancy complications, adverse-event rates were simila

48 first recognition in pregnancy, is a common pregnancy complication and a growing health concern.

49 ls of homocysteine (Hcy) are associated with pregnancy complications and adverse neonatal outcomes, s

50 Yet many pregnancy complications and birth defects that become mo

51 milial aggregation of common determinants of pregnancy complications and cardiovascular disease is th

52 Pregnancy complications and cardiovascular disease share

53 anism underlying maternal smoking-associated pregnancy complications and developmental disorders.

54 ause intrauterine infections associated with pregnancy complications and fetal abnormalities.

55 CVD prevention, as well as the link between pregnancy complications and future CVD risk, were identi

56 uctive failure linking subfertility and late pregnancy complications and has allowed us to reject pra

57 ta/increta/percreta is associated with major pregnancy complications and is thought to be becoming mo

58 This study reported pregnancy complications and neonatal outcomes for 49 liv

59 We aimed to present an overview of reported pregnancy complications and neonatal sequelae of materna

60 hed a mouse model that provided evidence for pregnancy complications and placental anti-angiogenesis

61 is crucial in understanding the etiology of pregnancy complications and prevention of congenital inf

62 immunity, often asymptomatic, and linked to pregnancy complications and risk of viral infection.

63 atios characterized the relationship between pregnancy complications and subsequent hospitalization f

64 t biology and sheds light on the etiology of pregnancy complications and the in utero programming of

65 Excessive weight gain is linked to pregnancy complications and to long-term maternal and ch

66 on disorders, including neural tube defects, pregnancy complications, and Alzheimer's disease.

67 smoking status, maternal educational level, pregnancy complications, and ambient temperature.

68 of counseling BMT patients about fertility, pregnancy complications, and potential birth defects is

69 ty, insurance, prepregnancy body mass index, pregnancy complications, and smoking or drinking during

70 terine growth restriction (IUGR) are serious pregnancy complications, and the triggers and mediators

71 cental infections represent a major cause of pregnancy complications, and yet the underlying molecula

72 w birth weight infants or who suffer related pregnancy complications are also at increased risk.

73 study were to determine whether PDG-induced pregnancy complications are associated with placental ap

74 with or without thrombotic manifestations or pregnancy complications are limited.

75 ight versus tight control of hypertension on pregnancy complications are unclear.

76 es, in particular better prophylaxis of late pregnancy complications, are urgently needed for obstetr

77 ndings have implications for immune-mediated pregnancy complications, as well as for our general unde

78 POINTS: Chronic fetal hypoxaemia is a common pregnancy complication associated with intrauterine grow

79 ental nutrient transport and fetal growth in pregnancy complications associated with altered maternal

80 s study, we examine the role of TNF-alpha in pregnancy complications associated with aPL Abs in a mur

81 ew insights in understanding and alleviating pregnancy complications associated with gestational hypo

82 We investigated whether pregnancy complications associated with low birthweight

83 nd B cell dysfunction has been implicated in pregnancy complications associated with PTL, the functio

84 ctives were to describe the epidemiology and pregnancy complications associated with severe ICP and t

85 of M2-skewed immunosuppressive cytokines and pregnancy-complication-associated fibronectin-1.

86 lms tumor (WT) diagnosed during childhood on pregnancy complications, birth weight, and the frequency

87 atosus (SLE) have fewer live births and more pregnancy complications, but can have successful live bi

88 urrent, especially severe, placenta-mediated pregnancy complications, but further research is require

89 Maternal asthma is associated with serious pregnancy complications, but newborn morbidity is unders

90 n, leading to infertility, or predisposes to pregnancy complications by rendering the feto-maternal i

91 Pregnancy complications can be unpredictable and many wo

92 as chronic infections, autoimmune diseases, pregnancy complications, cancers, and transplant failure

93 or cell hierarchy and may help us understand pregnancy complications caused by a defective placental

94 ytopoiesis and platelet production following pregnancy complications characterized by placental insuf

95 LMWH had recurrent severe placenta-mediated pregnancy complications compared with 127 (42.9%) of 296

96 Preeclampsia is a serious pregnancy complication diagnosed by signs of widespread

97 increased habitual spontaneous abortion and pregnancy complications (eg, placental abruption and pre

98 ndering them more susceptible to devastating pregnancy complications (especially preterm birth), HIV

99 Problems after delivery and pregnancy complications generally had low validity and r

100 ernal adaptive immune system to postsurgical pregnancy complications has not been explored.

101 oman with recurrent severe placenta-mediated pregnancy complications in her 2 pregnancies asks: Will

102 also shed light on the pathogenesis of many pregnancy complications in human, such as recurrent spon

103 Pregnancy complications in IL-10(-/-) mice were associat

104 rin help prevent recurrent placenta-mediated pregnancy complications in my next pregnancy?

105 bolism, pregnancy loss, or placenta-mediated pregnancy complications in pregnant women with thromboph

106 understanding the role of fetal NK cells in pregnancy complications in which NK cells could be invol

107 novel mechanism of pathogenesis for certain pregnancy complications in which there is engagement of

108 Thus, nadroparin did not prevent late-pregnancy complications in women at risk of recurrence.

109 ts of low-molecular-weight heparin (LMWH) on pregnancy complications in women with prior pregnancy lo

110 t heparins are widely used to try to prevent pregnancy complications.In this issue of Blood, Martinel

111 Late pregnancy complications include gestational diabetes and

112 Pregnancy complications included toxemia, lupus flare, g

113 o gain insights into the aetiology of common pregnancy complications, including intra-uterine growth

114 dation, hearing loss, visual impairment, and pregnancy complications, including intrauterine growth r

115 as been implicated as a pathogenic factor in pregnancy complications, including IUGR; however, the ro

116 ancy; impaired remodeling is associated with pregnancy complications, including late miscarriage, pre

117 insight into the pathogenesis of many human pregnancy complications, including preeclampsia, intraut

118 In addition to immediate implications for pregnancy complications, increasing evidence implicates

119 in vivo and in vitro and protected mice from pregnancy complications induced by aPL antibodies.

120 o maternal hyperglycemia, a common metabolic pregnancy complication, is of public health significance

121 ould be regarded as an indicator of possible pregnancy complications, not necessarily as a sign of ad

122 4; 95% confidence interval, 1.00-2.38), or a pregnancy complication (odds ratio, 1.78; 95% confidence

123 TNF blockade as a potential therapy for the pregnancy complications of APS.

124 eases (adjusted OR 3.69 [95% CI 1.78-7.66]), pregnancy complications or miscarriages (3.54 [1.47-8.55

125 Recurrence of pregnancy complications predisposing to SIDS could partl

126 The pregnancy complication preeclampsia (PE), which occurs i

127 In the pregnancy complication preeclampsia, extravillous tropho

128 ailures in this transformation accompany the pregnancy complication preeclampsia.

129 In turn, many idiopathic pregnancy complications proposed to originate from disru

130 the matching effect could be associated with pregnancy complications rather than with schizophrenia p

131 also increase the risk of placenta-mediated pregnancy complications (severe pre-eclampsia, small-for

132 ated disease, previous spontaneous abortion, pregnancy complications, smoking (since 1991), and body

133 Pregnancy complications (spontaneous abortion, intrauter

134 Reciprocally, many human pregnancy complications stemming from inadequacies in fe

135 For women without pregnancy complications, subtraction of 270 days from th

136 Prenatal cytomegalovirus infection may cause pregnancy complications such as intrauterine growth rest

137 pressed by dNK reduces development of severe pregnancy complications such as miscarriages and preterm

138 uding human immunodeficiency virus (HIV) and pregnancy complications such as preterm birth.

139 Uncovering the causes of pregnancy complications such as preterm labor requires g

140 ly viewed as most appropriate for women with pregnancy complications, such as HIV.

141 al placentation and the later development of pregnancy complications, such as preeclampsia, fetal gro

142 that this may be the underlying mechanism of pregnancy complications, such as preterm delivery.

143 e infiltration may be an underlying cause of pregnancy complications, such as preterm labor or preecl

144 nherited thrombophilia and placenta-mediated pregnancy complications, such as recurrent pregnancy los

145 STRACT: Chronic fetal hypoxaemia is a common pregnancy complication that may arise from maternal, pla

146 uterine infections have been associated with pregnancy complications that are also linked with increa

147 f of pregnancy, and no history of or current pregnancy complications that might have impaired fetal g

148 We observed combinations of pregnancy complications that predict high risk of death

149 studies have investigated the combination of pregnancy complications that predict risk for cardiovasc

150 betes, obesity, and overweight are prevalent pregnancy complications that predispose offspring to neu

151 f the relation of the occurrence of multiple pregnancy complications to CVD death over 5 decades in a

152 The relationship of pregnancy complications to future chronic disease is app

153 hat maternal inflammation can lead to severe pregnancy complications via a mechanism that involves in

154 The occurrence of pregnancy complications was not significantly different

155 en with known allergies to prostaglandins or pregnancy complications were excluded.

156 Pregnancy complications were few and manageable.

157 estational diabetes mellitus (GDM), a common pregnancy complication which has short-term and long-ter

158 Preeclampsia is a major pregnancy complication with potential short- and long-te